Licensed injectable GLP-1 receptor agonists such as semaglutide and dulaglutide are available for appropriate patients through NHS prescribing
These resources are here to support you as you embark on a safe and effective path to achieving your weight loss goals with GLP-1 medications
Surprisingly, multiple ALS-causative mutations in FUS/TLS increase FUS/TLS interaction with SMN, thereby affecting the normal function of SMN by both reducing Gem bodies and changing steady-state levels of some snRNAs in transgenic mouse tissues and patient fibroblasts expressing mutant FUS/TLS
A Research Use Only statement does not settle classification where the wider page uses injury, recovery, treatment, injection or personal-use claims
These autophosphorylation events and conformational changes create multiple docking sites for a variety of endogenous substrates including members of the insulin receptor substrate (IRS) family which associate with IGF-1R via PTB and SH2 domains, growth receptor binding protein-2 (Grb2) which binds to specific motifs in the IGF-1 receptor as well as in IRS, and the p85 subunit of phosphatidyl inositol-3 kinase (PI3K) which binds to other specific motifs within IRS